The 93^rd CMEF concluded in Shanghai on April 12, 2026.

The theme of the conference was "Innovative Fusion · Infinite Leap." But at ANKE, we have another narrative.

It is not only about the leap, but also about where the leap comes from.

Four decades, the mark of years quietly emerges.
More than 30 "China's Firsts" — from filling gaps to independent R&D, conquering challenges one by one, accumulating quantitative change bit by bit,
ultimately crystallizing into the testimony of time.

Moment of Fusion: High-end Imaging Matrix Ignites the Venue

ANKE exhibited a full range of high-end product matrices covering CT, MRI, X-Ray, and minimally invasive treatments, with multiple core technologies attracting industry attention. Among them, the deep embedding of AI enables imaging equipment not only to "see" but also to begin to "understand." It is not a decorative single function, but a full-chain empowerment system running through patient positioning, scan localization, dose control, artifact suppression, spectral imaging, image noise reduction, and assisted diagnosis.

Leap Dialogue: Industry Experts Discuss the Future of Medical Imaging

During the exhibition, ANKE hosted the "Leap · Dialogue" thematic exchange and press conference. Medical imaging experts, end-users, and industry chain partners from around the world gathered together. In light of the core new products launched this time, in-depth discussions were held on topics such as "Iterative Upgrading of Domestic High-end Medical Imaging," "Deep Integration of AI and Medical Imaging," and "Enhancing Clinical Diagnostic Capacity of Medical Imaging."

President Zhu Liming of ANKE:

"Quantitative change is an invisible leap, and a leap is visible quantitative change. After four decades of hard work, we now embark on a new journey. Standing at the new starting point of the 40^th anniversary, ANKE will always focus on core clinical needs, maintain strategic determination for independent innovation, and continuously deepen the integrated development of production, academia, research, medicine, and application. Currently, AI technology is profoundly reshaping the landscape of the medical industry. In the future, we will deeply cultivate the AI digital intelligence track, using hardcore Chinese AI imaging innovation to help balance global medical resources — this is ANKE's direction and our commitment."

Global Presence: Chinese Intelligent Manufacturing Benefits Global Healthcare

From its origin in Shenzhen to a global footprint, ANKE continuously injects Chinese strength into the global health cause with high-quality products and services. Built on forty years of accumulation, we not only deeply cultivate tertiary hospitals and empower primary healthcare in the domestic market, but also bring accurate and efficient medical imaging solutions to the world — our products are sold in more than 80 countries and regions, serving over 20,000 overseas medical institutions, making us a trusted imaging equipment partner for healthcare providers worldwide.

In the future, ANKE will continue to deepen its global presence, build localized service platforms, and join hands with international partners to bring China's high-end imaging technology to more people.

Qualitative change requires a long process of quantitative change, and an energy leap requires sufficient accumulation. When and where a leap occurs often has no clear boundary. But we firmly believe that —

Quantitative change never fails time.

Particles are still colliding, energy is still converging.
Let us wait together
for the next leap from quantitative change to qualitative change.